| Brand Name | TYRX ABSORBABLE ANTIBACTERIAL ENVELOPE |
| Common Device Name | MESH, SURGICAL, POLYMERIC |
| Manufacturer (Section D) |
| MEDTRONIC, INC. |
| 8200 coral sea street ne |
| mounds view MN 55112 |
|
| Manufacturer (Section G) |
| MEDTRONIC, INC. |
| 8200 coral sea street ne |
|
| mounds view MN 55112 |
|
| Manufacturer Contact |
|
paula
bixby
|
| 8200 coral sea st ne |
| mounds view, MN 55112
|
|
7635055378
|
|
| MDR Report Key | 14245556 |
| Report Number | 2182208-2022-01369 |
| Device Sequence Number | 5016102 |
| Product Code |
FTL
|
| UDI-Device Identifier | 00763000307899 |
| UDI-Public | 00763000307899 |
| Combination Product (Y/N) | N |
| Initial Reporter State | NY |
| Initial Reporter Country | US |
| PMA/510(K) Number | K150291 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Implanted Year | 2022 |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Health Professional,Company Representative |
| Initial Reporter Occupation |
Physician
|
| Type of Report
| Initial |
| Report Date (Section B) |
04/28/2022 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Lay User/Patient
|
| Device Expiration Date | 05/02/2022 |
| Device Model Number | NMRM6122 |
| Device Catalogue Number | NMRM6122 |
| Device Lot Number | R146523 |
| Was Device Available for Evaluation? |
No
|
| Is the Reporter a Health Professional? |
Yes
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 04/13/2022 |
| Initial Report FDA Received Date | 04/28/2022 |
| Date Device Manufactured | 05/07/2021 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | 97715 PAIN STIM IPG, 977A260 PAIN STIM LEAD X2 |
| Outcome Attributed to Adverse Event |
Required Intervention;
Hospitalization;
|
| Patient Age | 38 YR |
| Patient Sex | Male |